Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lyrus Life Sciences is a research-driven pharmaceutical company headquartered in Bengaluru, India, specializing in the development of complex generics and value-added medicines. The company focuses on innovative drug delivery systems (NDDS) to improve patient compliance and therapeutic outcomes across various therapeutic areas, including neurology, pain management, and cardiovascular health. Lyrus operates a state-of-the-art R&D center and partners with global pharmaceutical companies to provide end-to-end product development services from formulation to commercialization. Their portfolio includes a range of differentiated products such as fast-dissolving tablets, modified-release formulations, and topical applications. By focusing on high-entry-barrier products, Lyrus establishes itself as a key player in the specialty pharmaceutical space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lyrus.